Suppr超能文献

用于治疗脓毒症、哮喘和特应性皮炎等炎症性疾病的重新定位药物。

Repositioned Drugs for Inflammatory Diseases such as Sepsis, Asthma, and Atopic Dermatitis.

作者信息

Prakash Annamneedi Venkata, Park Jun Woo, Seong Ju-Won, Kang Tae Jin

机构信息

Convergence Research Center, Department of Pharmacy and Institute of Chronic Disease, Sahmyook University, Seoul 01795, Republic of Korea.

出版信息

Biomol Ther (Seoul). 2020 May 1;28(3):222-229. doi: 10.4062/biomolther.2020.001.

Abstract

The process of drug discovery and drug development consumes billions of dollars to bring a new drug to the market. Drug development is time consuming and sometimes, the failure rates are high. Thus, the pharmaceutical industry is looking for a better option for new drug discovery. Drug repositioning is a good alternative technology that has demonstrated many advantages over drug development, the most important one being shorter drug development timelines. In the last two decades, drug repositioning has made tremendous impact on drug development technologies. In this review, we focus on the recent advances in drug repositioning technologies and discuss the repositioned drugs used for inflammatory diseases such as sepsis, asthma, and atopic dermatitis.

摘要

药物发现和药物开发过程耗费数十亿美元才能将一种新药推向市场。药物开发耗时且有时失败率很高。因此,制药行业正在寻找更好的新药发现选择。药物重新定位是一种很好的替代技术,已证明比药物开发具有许多优势,其中最重要的是缩短药物开发时间线。在过去二十年中,药物重新定位对药物开发技术产生了巨大影响。在本综述中,我们重点关注药物重新定位技术的最新进展,并讨论用于治疗脓毒症、哮喘和特应性皮炎等炎症性疾病的重新定位药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4548/7216745/b14a46d1df14/BT-28-222-f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验